title: [Tegafur gimeracil oteracil potassium capsule induced acute interstitial lung disease: a case report].
authors.affiliation: Department of Oncology, Hainan Branch of PLA General Hospital, Sanya 572000, China.
authors.forename: Fangfang
authors.initials: F
authors.lastname: Li
authors.affiliation: Department of Oncology, Hainan Branch of PLA General Hospital, Sanya 572000, China.
authors.forename: Yanfang
authors.initials: Y
authors.lastname: Ju
authors.affiliation: Department of Oncology, Hainan Branch of PLA General Hospital, Sanya 572000, China.
authors.forename: Yin
authors.initials: Y
authors.lastname: Guan
authors.affiliation: Department of Oncology, Hainan Branch of PLA General Hospital, Sanya 572000, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Zhao
mesh_terms: D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002214:Capsules; D004338:Drug Combinations; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008297:Male; D010094:Oxonic Acid / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects; D005641:Tegafur / Q000009:adverse effects; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D002214:Capsules; D004338:Drug Combinations; D011725:Pyridines; C586502:tegafur-gimeracil-oteracil; D005641:Tegafur; D010094:Oxonic Acid